Pharmacokinetics of anticancer drugs in cerebrospinal fluid

Annals of Pharmacotherapy

Volumn 32, Issue 10, 1998, Pages 1008-1012

  Morikawa, Norifumi ^a   Mori, Teruaki ^a   Kawashima, Hisanori ^a   Takeyama, Masaharu ^a   Hori, Shigeaki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Cytarabine hydrochloride; Methotrexate; Nimustine

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; METHOTREXATE; NIMUSTINE;

AGED; ARTICLE; BRAIN TUMOR; BRAIN VENTRICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DRUG CEREBROSPINAL FLUID LEVEL; DRUG HALF LIFE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GLIOBLASTOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LUMBAR SPINAL CORD; PRIORITY JOURNAL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DRUG ADMINISTRATION ROUTES; FEMALE; GLIOBLASTOMA; HUMANS; INJECTIONS, SPINAL; METHOTREXATE; NIMUSTINE; PERFUSION;

EID: 0031767380     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.17362     Document Type: Article

References (17)

1. Wasserstom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759-72.
2. Yap H, Yap B, Rasmussen S, Levens ME, Hortobagyi GN, Blumenschein GR. Treatment for meningeal carcinomatosis in breast cancer. Cancer 1982;49:219-22.
3. Giannone L, Greco FA, Hainsworth JD. Combination intraventricular chemotherapy for meningeal neoplasm. J Clin Oncol 1986;4:68-73.
4. Hitchines RN, Bell DR, Woods RL, Levi JA. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 1987;5:1655-62.
5. Theodore WH, Gendelman S. Meningeal carcinomatosis. Arch Neurol 1981;38:696-9.
6. Bleyer WA, Drake JC, Chabner BA. Neurotoxicity and elevated cerebrospinal fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973;289:770-3.
7. Kochi M, Kuratsu J, Mihara Y, Takaki S, Seto H, Uemura S, et al. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride (ACNU). Neurosurgery 1993;33:817-23.
8. Nakagawa H, Fujita T, Kubo S, Izumoto S, Nakajima Y, Tsuruzono K, et al. Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: a pilot study in 13 patients. Surg Neurol 1996;45:256-64.
9. Morikawa N, Mori T, Kawashima H, Fujiki M, Abe T, Kaku T, et al. Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors. Eur J Clin Pharmacol (in press).
10. Nakamura K, Asami M, Kawada K, Sasahara K. Quantitative determination of ACNU (3-[(4-amino-2-methyl-5-pyrimidinyl) methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride), a new water-soluble anti-tumor nitrosourea, in biological fluids and tissues of patients by high-performance liquid chromatography. I. Analytical method and pharmacokinetics. Ann Rep Sankyo Res Lab 1977;29:66-74.
11. Linssen P, Drenthe-Schonk A, Wessels H, Haanen C. Determination of 1-β-D-arabinofuranosylcytosine and 1-β-arabinofuranosyluracil in human plasma by high-performance liquid chromatography. J Chromatogr 1981;223:371-8.
12. Breithaupt H, Schick J. High-pressure liquid chromatography analysis of cytarabine and its metabolite 1-β-D-arabinofuranosylcytosine in biological fluids. J Chromatogr 1981;225:99-106.
13. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobio-Dyn 1981;4:879-85.
14. Bleyer WA. Current status of intrathecal chemotherapy for human meningeal neoplasmas. Natl Cancer Inst Monogr 1977;46:171-8.
15. Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975;293:161-6.
16. Rieselbach RE, Chiro GD, Freireich EJ, Rail DP. Subarachnoid distribution of drugs after lumbar injection. N Engl J Med 1962;267:1273-8.
17. Levin VA, Byrd D, Campbell J, Giannini DD, Borcich JK, Davis RL. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitrosourea and other nitrosoureas in beagles. Cancer Res 1985;45:3803-9.